HOME
keyboard_arrow_right
Products
keyboard_arrow_right
Pharmaceutical
keyboard_arrow_right
Automated Freeze-Thaw System
keyboard_arrow_right
RoSS.pFTU XL
Single Use Support
RoSS.pFTU XL

RoSS.pFTU XL – Automated Freeze-Thaw System | Up to 500L
The RoSS.pFTU XL is an advanced automated plate freeze-thaw system featuring advanced top-and-bottom stainless steel plate contact technology for efficient freezing and uniform thawing. It is supplier-agnostic, supporting single-use bag containers up to 50L in volume.
With a capacity to process up to 500L of drug substance, the non-liquid nitrogen system reduces operational complexity and costs. Its scalability ensures smooth transitions from process development to large-scale commercial production while maintaining consistent freeze-thaw performance.
Fully compliant with cGMP and 21 CFR Part 11 standards, RoSS.pFTU XL guarantees regulatory compliance and data integrity. The system’s advanced freezing technology and precise temperature control provide stable and accurate thermal management, making it an ideal solution for large-volume drug substances such as monoclonal antibodies (mAbs) and mRNA vaccines.
The RoSS.pFTU XL is an advanced automated plate freeze-thaw system featuring advanced top-and-bottom stainless steel plate contact technology for efficient freezing and uniform thawing. It is supplier-agnostic, supporting single-use bag containers up to 50L in volume.
With a capacity to process up to 500L of drug substance, the non-liquid nitrogen system reduces operational complexity and costs. Its scalability ensures smooth transitions from process development to large-scale commercial production while maintaining consistent freeze-thaw performance.
Fully compliant with cGMP and 21 CFR Part 11 standards, RoSS.pFTU XL guarantees regulatory compliance and data integrity. The system’s advanced freezing technology and precise temperature control provide stable and accurate thermal management, making it an ideal solution for large-volume drug substances such as monoclonal antibodies (mAbs) and mRNA vaccines.